Carbenicillin Indanyl Sodium, an Orally Active Derivative of Carbenicillin

A. R. English(Pfizer (United States)), John E. Lynch(Pfizer (United States)), Verne A. Ray(Pfizer (United States)), James A. Retsema(Pfizer (United States))
Antimicrobial Agents and Chemotherapy
March 1, 1972
Cited by 42


Related Papers